Kamada Ltd. (KMDA)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$7.45
+0.13%
Mkt Cap $413.61M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$12.00
Range $11.00 – $13.00
Implied Upside
+61.1%
Consensus $12.00 vs current $7.45